Harbin Gloria Pharmaceuticals Co.Ltd(002437) (SZ Harbin Gloria Pharmaceuticals Co.Ltd(002437) , closing price: 2.4 yuan) announced on April 27 that in addition to this subsidy, the accumulated various government subsidies received by the company and its subsidiaries from January to March 2022 have increased the total profit of the company in 2022 by 4.462 million yuan.
From January to December 2021, Harbin Gloria Pharmaceuticals Co.Ltd(002437) the composition of operating revenue is: chemical drugs account for 94.66%, traditional Chinese medicine account for 4.72% and others account for 0.62%.
Harbin Gloria Pharmaceuticals Co.Ltd(002437) ‘s general manager is Diao xiuqiang, male, 45 years old, with a master’s degree background.
